Leyden Labs

Leiden-based biotech developing intranasal protection against respiratory viruses; its June 2026 EUR 40M round drew Invest-NL, EIC and the Gates Foundation.

View on the globe

$46.4MEquity raised in 2025–20262025 — · 2026 $46.4M · 1 equity round
$46.4MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed

Rounds over time log-scaled amounts

Funding history: 1 round from 25 Jun 2026 to 25 Jun 2026, $46.4M equity disclosed. Earlier rounds exist but are not sourced.25 Jun 2026: Funding round (investor consortium), $46.4M$1M$3M$10M$30M$100MEarlier rounds exist but are not sourced yet← earlier rounds not sourced2026Q2Q3Q42027Equity round25 Jun 2026 · Funding round (investor consortium) · $46.4MOther · $46.4M
Funding history: 1 round from 25 Jun 2026 to 25 Jun 2026, $46.4M equity disclosed. Earlier rounds exist but are not sourced.25 Jun 2026: Funding round (investor consortium), $46.4M$1M$3M$10M$30M$100MEarlier rounds exist but are not sourced yetearlier rounds not sourced2026Q2Q3Q42027Equity round25 Jun 2026 · Funding round (investor consortium) · $46.4M$46.4M

Funding history 1 round · 1 source

Earlier rounds not yet sourced. Leyden Labs raised before 25 Jun 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.

  1. Funding round (investor consortium)
    Amount$46.4MEUR 40M
    Post-money—
    ✓ Confirmed
    Also
    Invest-NL, EIC Fund, Gates Foundation Strategic Investment Fund, ClavystBio
    Note
    EUR 40M round (Invest-NL puts in EUR 10M); the company release (Business Wire, 24 Jun 2026 per URL) describes an international consortium of investors from Europe, the US and Asia, with other investors unnamed. No lead investor is stated in the Invest-NL article or the release; one aggregator's 'led by EIC Fund' is not supported and is not used. The round label is not stated. Legal name Leyden Laboratories B.V. (from release). EIC funding via the STEP programme. USD figure is an approximate conversion at 1.16 USD/EUR (median of source-stated conversions in the dataset for 2026Q2).
    Sources
  2. Earlier rounds not yet sourced

Investors 4

  • ClavystBio
  • EIC Fund
  • Gates Foundation Strategic Investment Fund
  • Invest-NL

Highlighted investors led at least one equity round; the number is equity rounds taken part in.

Related companies shared investors

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Leyden Labs and its logo are trademarks of their owners, used here for identification only.